Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
2018 · BMC Cancer · 66 citations
https://doi.org/10.1186/s12885-018-4217-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
201
Citations
8
h-index
8
i10-index
Danjing Yin is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Glycosylation and Glycoproteins Research. The author has an h-index of 8, co-authored 10 publications.
Click to start Chat